KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Operations: 2009-2024

Historic Cash from Operations for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $734.6 million.

  • Charles River Laboratories International's Cash from Operations fell 15.08% to $213.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.5 million, marking a year-over-year decrease of 5.86%. This contributed to the annual value of $734.6 million for FY2024, which is 7.41% up from last year.
  • As of FY2024, Charles River Laboratories International's Cash from Operations stood at $734.6 million, which was up 7.41% from $683.9 million recorded in FY2023.
  • Over the past 5 years, Charles River Laboratories International's Cash from Operations peaked at $760.8 million during FY2021, and registered a low of $546.6 million during FY2020.
  • Moreover, its 3-year median value for Cash from Operations was $683.9 million (2023), whereas its average is $679.4 million.
  • Per our database at Business Quant, Charles River Laboratories International's Cash from Operations surged by 39.19% in 2021 and then decreased by 18.55% in 2022.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Cash from Operations stood at $546.6 million in 2020, then spiked by 39.19% to $760.8 million in 2021, then fell by 18.55% to $619.6 million in 2022, then increased by 10.37% to $683.9 million in 2023, then rose by 7.41% to $734.6 million in 2024.